Company / Return on Equity (ROE)
Solventum Return on Equity (ROE) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
30.8%
FY2025
5-year range
11.4% / 30.8%
FY2022-FY2025
Trend
+90.4%
vs FY2024
Sector context
#8 of 148
Health Care
What the data says
Among 148 Health Care companies, Solventum is in the top 5% for return on equity (roe). Return on Equity (ROE) has increased for 3 consecutive years, from 11.4% in FY2022 to 30.8% in FY2025.
Based on SEC 10-K filings.
30.8% in FY2025 with a 3-year CAGR of +19.4%. Top quartile in the Health Care sector.
Improved from 11.5% to 30.8% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +19.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 5% in Health CareTop 5% of 148This company 30.8% Sector average -3.2%
▼
+1075.9% above sector average
Key checks
Key Insights
- Solventum's return on equity (roe) has grown for 3 consecutive years.
- In FY2025, return on equity (roe) increased 90.4% year-over-year.
- Currently 34.0pp above the Health Care sector average.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 30.8% | +90.4% |
| FY2024 | 16.2% | +40.3% |
| FY2023 | 11.5% | +0.9% |
| FY2022 | 11.4% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026